Why is Clovis Oncology Inc. (CLVS) up 43.02% from the day 1 this year?

At the end of the latest market close, Clovis Oncology Inc. (CLVS) was valued at $6.97. In that particular session, Stock kicked-off at the price of $7.50 while reaching the peak value of $7.52 and lowest value recorded on the day was $6.73. The stock current value is $6.78.

Recently in News on September 17, 2020, New Data Presented at ESMO Virtual Congress 2020 Highlight Breadth and Potential of Clovis Oncology Products and Pipeline. Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the data being presented as e-posters at the European Society for Medical Oncology (ESMO) Virtual Congress 2020. These include initial data from the Phase 1b part of the LIO-1 study of lucitanib in combination with Opdivo, new analyses of data from the pivotal Rubraca ARIEL3 and TRITON2 studies, initial data from the Phase 1b part of the SEASTAR study arm of Rubraca with Trodelvy™ (sacituzumab govitecan-hziy), and the first presentation of preclinical data for FAP-2286 Clovis’ novel peptide-targeted radionuclide therapy. You can read further details here


My Next COVID-19 Stock Alert Poised For Triple Digit Moves

Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.    

>> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer <<

Sponsored


Clovis Oncology Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $11.63 on 02/20/20, with the lowest value was $3.62 for the same time period, recorded on 03/17/20.

Clovis Oncology Inc. (CLVS) full year performance was 43.02%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Clovis Oncology Inc. shares are logging -61.00% during the 52-week period from high price, and 131.23% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.93 and $17.37.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1387703 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Clovis Oncology Inc. (CLVS) recorded performance in the market was -33.19%, having the revenues showcasing 4.42% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 659.79M, as it employees total of 484 workers.

Analysts verdict on Clovis Oncology Inc. (CLVS)

During the last month, 1 analysts gave the Clovis Oncology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts were recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 2 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.65, with a change in the price was noted -1.35. In a similar fashion, Clovis Oncology Inc. posted a movement of -16.54% for the period of last 100 days, recording 5,987,714 in trading volumes.

Clovis Oncology Inc. (CLVS): Technical Analysis

Raw Stochastic average of Clovis Oncology Inc. in the period of last 50 days is set at 65.29%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 64.53%. In the last 20 days, the company’s Stochastic %K was 72.60% and its Stochastic %D was recorded 82.46%.

Let’s take a glance in the erstwhile performances of Clovis Oncology Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -33.19%. Additionally, trading for the stock in the period of the last six months notably improved by 57.22%, alongside a boost of 43.02% for the period of the last 12 months. The shares increased approximately by 15.31% in the 7-day charts and went down by 27.45% in the period of the last 30 days. Common stock shares were driven by 4.42% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the Investchronicle.com pre-market morning brief 100% free